His research includes clinical trials of new therapies for neuromuscular conditions and he is National Principal Investigator of the Canadian Neuromuscular Disease Registry. He recently led the development of the Canadian Neurological Registry Best Practice Guidelines, which culminated in the formation of the Canadian Registry Network. Dr. Korngut kindly answered some questions about his work and motivation behind it for IMHA’s newsletter.